NC State College of Management names industry board for BioPharma Management Initiative
Raleigh, NC – North Carolina State University College of Management today announced the formation of a new Industry Advisory Board for its BioPharma Management Initiative. The announcement was made at the North Carolina Biotechnology Center (NCBC) during the third annual BioPharma Forum, co-sponsored by the BioPharma Management Initiative and NCBC.
Lou Arp, vice president of production operations at Eisai, Inc. will chair the new board, which is comprised of senior executives from life science and health care companies throughout the Research Triangle and surrounding communities. The board also includes academic leaders from NC State colleges and departments whose research and teaching are highly relevant to North Carolina’s growing life sciences economy.
“I am pleased to chair the new Industry Advisory Board for the BioPharma Management Initiative in NC State’s College of Management, and look forward to working with these seasoned executives over the coming months and years,” said Arp, who also participated on the initiative’s inaugural advisory board, whose terms ended earlier this year.
“My colleagues on the new board represent large and small biotechnology, pharmaceutical and advanced medical technology companies, with expertise in manufacturing, operations, business development, marketing, data management, clinical development, regulatory affairs and health care delivery,” Arp said. “Working with NC State’s outstanding faculty, I am confident we can help the college build an MBA concentration in biopharma management that is well known and highly regarded by life science companies internationally.”
The primary goals for establishing the board are to ensure that the BioPharma Management MBA curriculum matches industry needs and to maximize opportunities for industry-student interaction through project practicum courses, summer internships, and future employment. Industry board members will also identify industry experts to present guest lectures and provide insight for increasing awareness of the initiative and this MBA curriculum regionally, nationally and internationally. Academic board members will facilitate the establishment of cross-campus partnerships with the initiative and strengthen its research agenda.
“Although relatively young, the BioPharma Management MBA Concentration is one of the fastest growing within the Jenkins Graduate School of Management, with student enrollment expanding from 10 to nearly 40 in just three years,” said Richard Kouri, executive director of the BioPharma Management Initiative. “Regular input from life science executives, particularly those on our new Industry Advisory Board, is essential to ensure our curriculum continues to meet industry needs and that our students are well prepared to take management positions in large and small life science companies locally and globally.”
BioPharma Management is one of eight MBA concentrations offered in the College of Management’s recently endowed Jenkins Graduate School of Management. The other concentrations of study are entrepreneurship and technology commercialization, finance, information technology, services management, innovation management, marketing, and supply chain management. With its primary focus on the management of technology and innovation, the NC State College of Management places a high value on industry interaction and collaboration.
“The involvement of industry leaders, such as those on the new BioPharma Management Initiative Advisory Board, is critical to ensuring we are providing our students with curricula and experiences that will help them advance their careers,” said Steve Allen, associate dean for the Jenkins Graduate School of Management and associate dean for research at the NC State College of Management. “We greatly appreciate the time and commitment of our industry and academic partners. This type of close interaction is a key component of our ‘active learning’ model of teaching.”
Following are the industry members of the BioPharma Management Initiative Advisory Board:
- Lou Arp, vice president production operations, Eisai, Research Triangle Park, N.C.
- Jeff Clark, managing general partner, Aurora Funds, Inc., Durham, N.C.
- John Cox, senior vice president of global manufacturing and general manager, Biogen Idec, Durham N.C.
- Prabhavathi Fernandes, president and chief executive officer, Cempra Pharmaceuticals, Chapel Hill, N.C.
- Myla-Lai Goldman, executive vice president, medical director and chief scientific officer of Laboratory Corporation of America, Holdings, Burlington, N.C.
- Bruce Kaylos, managing director of Wyeth Biotech, Sanford, N.C.
- Judy O’Neal, senior vice president, public affairs and chief of staff, Office of the President, WakeMed Health & Hospitals, Raleigh, N.C.
- Mark Paige, vice president, technical operations, Novozymes North America, Inc., Franklinton, N.C.
- Dan Pelak, president and chief executive officer, InnerPulse, Research Triangle Park, N.C.
- Joe Schachle, executive vice president, chief of commercial and corporate operations, Inspire Pharmaceuticals, Inc., Durham, N.C.
- Paula Brown Stafford, executive vice president, global data management, Quintiles Transnational Corp., Research Triangle Park, N.C.
- Scott Uknes, vice president, business development, Athenix Corp., Research Triangle Park, N.C.
- Rick Williams, director, BATON, North Carolina Biotechnology Center, Research Triangle Park, N.C.
Academic members of the BioPharma Management Initiative Industry Advisory Board are:
- Leslie Alexandre, director, corporate relations, health care and life sciences, NC State College of Management
- Steve Allen, associate dean, Jenkins Graduate School of Management, and associate dean for research, NC State College of Management
- Prema Arasu, interim assistant dean, student and international affairs, The Graduate School, and director, International Programs, NC State College of Veterinary Medicine
- Michael Flickinger, professor of chemical and biomolecular engineering and microbiology, and BTEC associate director, NC State College of Engineering
- Richard Kouri, executive director, BioPharma Management Initiative, and professor of practice, NC State College of Management
- Daniel Kuckel, MBA student and president, BioPharma Management Club, NC State College of Management
- Mitzi Montoya, Zelnak Professor of Marketing Innovation and executive director, Services & Product Innovation Management Initiative, NC State College of Management
- Paul Mugge, director, Center for Innovation Management Studies, and professor of innovation, NC State College of Management
- Troy Nagle, professor and founding chair, NC State University/University of North Carolina at Chapel Hill Joint Degree in Biomedical Engineering, NC State College of Engineering
- Stephen Schanz, teaching assistant professor, Department of Management, Innovation and Entrepreneurship, NC State College of Management
- Sam Straight, executive-in-residence, Supply Chain Management and Biopharma Management, NC State College of Management
- David Winwood, associate vice chancellor, Technology Development and Innovation, NC State University
- Read More:CarolinaNewsWire







